Search by Drug Name or NDC

    NDC 55111-0496-60 capecitabine 150 mg/1 Details

    capecitabine 150 mg/1

    capecitabine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Dr. Reddy's Laboratories Limited. The primary component is CAPECITABINE.

    Product Information

    NDC 55111-0496
    Product ID 55111-496_3ed652e7-8f96-5524-8224-b621ea858c03
    Associated GPIs 21300005000320
    GCN Sequence Number 039780
    GCN Sequence Number Description capecitabine TABLET 150 MG ORAL
    HIC3 V1B
    HIC3 Description ANTINEOPLASTIC - ANTIMETABOLITES
    GCN 31611
    HICL Sequence Number 018385
    HICL Sequence Number Description CAPECITABINE
    Brand/Generic Generic
    Proprietary Name capecitabine
    Proprietary Name Suffix n/a
    Non-Proprietary Name capecitabine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name CAPECITABINE
    Labeler Name Dr. Reddy's Laboratories Limited
    Pharmaceutical Class Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA204345
    Listing Certified Through 2024-12-31

    Package

    NDC 55111-0496-60 (55111049660)

    NDC Package Code 55111-496-60
    Billing NDC 55111049660
    Package 60 TABLET in 1 BOTTLE (55111-496-60)
    Marketing Start Date 2020-12-10
    NDC Exclude Flag N
    Pricing Information N/A